THÔNG TIN TÀI LIỆU
multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population J Cardiovasc Electrophysiol 2006;17:41–46 120 Stout KK, Broberg CS, Book WM, et al American heart association council on clinical cardiology, Council on functional genomics and translational biology, and council on cardiovascular radiology and imaging Chronic heart failure in congenital heart disease: a scientific statement from the American heart association Circulation 2016;133:770–801 121 Weller RJ, Weintraub R, Addonizio LJ, et al Outcome of idiopathic restrictive cardiomyopathy in children Am J Cardiol 2002;90:501–506 122 Colan SD, Lipshultz SE, Lowe AM, et al Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the pediatric cardiomyopathy registry Circulation 2007;115:773–781 123 Towbin JA, Lowe AM, Colan SD Incidence, causes, and outcomes of dilated cardiomyopathy in children JAMA 2006;296:1867–1876 124 Rusconi P, Wilkinson JD, Sleeper LA, et al Pediatric cardiomyopathy registry investigators Differences in presentation and outcomes between children with familial dilated cardiomyopathy and children with idiopathic dilated cardiomyopathy: a report from the pediatric cardiomyopathy registry study group Circ Heart Fail.2017;10 [pii: e002637] 125 Daubeney PE, Nugent AW, Chondros P, et al National Australian childhood cardiomyopathy study Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study Circulation 2006;114:2671–2678 126 Sleeper LA, Towbin JA, Colan SD, et al Pediatric cardiomyopathy registry investigators Health-related quality of life and functional status are associated with cardiac status and clinical outcome in children with cardiomyopathy J Pediatr 2016;170:173–180 127 den Boer SL, Baart SJ, van der Meulen MH, et al Parent reports of health-related quality of life and heart failure severity score independently predict outcome in children with dilated cardiomyopathy Cardiol Young 2017;27:1194– 1202 128 Price JF, Thomas AK, Grenier M, et al B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction Circulation 2006;114:1063–1069 129 Auerbach SR, Richmond ME, Lamour JM, et al BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the pediatric carvedilol trial Circ Heart Fail.2010;3:606–611 130 Miyamoto SD, Karimpour-Fard A, Peterson V, et al Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy J Heart Lung Transplant 2015;34:724–733 ... cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction Circulation 2006;114:1063–1069 129 Auerbach SR, Richmond ME, Lamour JM, et al BNP levels predict outcome in pediatric heart... failure patients: post hoc analysis of the pediatric carvedilol trial Circ Heart Fail.2010;3:606–611 130 Miyamoto SD, Karimpour-Fard A, Peterson V, et al Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy... between children with familial dilated cardiomyopathy and children with idiopathic dilated cardiomyopathy: a report from the pediatric cardiomyopathy registry study group Circ Heart Fail.2017;10 [pii: e002637] 125 Daubeney PE, Nugent AW, Chondros P, et al
Ngày đăng: 22/10/2022, 12:19
Xem thêm: